NuCana PLC (NASDAQ:NCNA)

0.64
Delayed Data
As of Jul 01
 -0.085 / -11.72%
Today’s Change
0.52
Today|||52-Week Range
3.32
-73.11%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$41.1M

Company Description

NuCana Plc engages in the development of technology platform for the treatment of patients with cancer. Its Protide technology consists of acelarin, NUC-3373 and NUC-7738. The company was founded by Hugh Stephen Griffith and Christopher Barry Wood on January 28, 1997 and is headquartered in Edinburgh, the United Kingdom.

Contact Information

NuCana Plc
3 Lochside Way
Edinburgh Midlothian EH12 9DT
P:441313571111
Investor Relations:

Employees

Shareholders

Mutual fund holders7.84%
Other institutional4.33%
Individual stakeholders--

Top Executives

Hugh Stephen GriffithChief Executive Officer & Executive Director
Donald MunozChief Financial Officer
Elisabeth OelmannSenior VP-Medical & Clinical Development
Jeffrey D. BlossChief Medical Officer
Theresa Margaret BruceSenior Vice President-Clinical Operations